
|Articles|February 7, 2004
Clinical comparison pushes AD treatment toward potency chart
Interim data from three studies released at the 62nd annual conferenceof the American Academy of Dermatology support preliminary data presentedlast month demonstrating that tacrolimus ointment (Protopic, Fujisawa) ismore effective than pimecrolimus cream (Elidel, Novartis) in the treatmentof adult and pediatric patients with atopic dermatitis.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
The Emerging Role of Oral Peptide Therapeutics in Dermatology
2
Novel Botanical Moisturizer Demonstrates Superior Efficacy Over Metronidazole in Phase 2 Rosacea Trial
3
Rese-cel Data Support Registrational Strategy Across Dermatomyositis, Systemic Sclerosis, Lupus
4
Suneel Chilukuri, MD on the Crucial Role of Barrier Repair and Tailored BPO Therapy
5














